Victor Sandor

CIK: 0001620368

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)9 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

ABCL

AbCellera Biologics Inc.

Director

KYMR

Kymera Therapeutics, Inc.

Director

PRLD

Prelude Therapeutics Inc

Director

ADCT

ADC Therapeutics SA

Director

MRUS

Merus N.V.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

ABCL
AbCellera Biologics Inc.
Jul 1, 2026
Award(A)
Share option (right to buy)
Direct
152.2K shares-
KYMR
Kymera Therapeutics, Inc.
Jun 24, 2026
Award(A)
Stock Option (Right to Buy)
Direct
6.1K shares-
PRLD
Prelude Therapeutics Inc
Jun 9, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
38K shares-
ADCT
ADC Therapeutics SA
Jun 3, 2026
Tax Payment(F)
Direct
12.6K shares at avg. $3.08$39K
ADCT
ADC Therapeutics SA
Jun 1, 2026
Award(A)
Direct
45K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
16.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
13.2K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
8.8K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
14.4K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
6.1K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
8.6K shares-
MRUS
Merus N.V.
Dec 12, 2025
Disposition(D)
Share Option (right to buy)
Direct
17K shares-
PRLD
Prelude Therapeutics Inc
Nov 5, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
121.3K shares-
KYMR
Kymera Therapeutics, Inc.
Jun 25, 2025
Award(A)
Stock Option (Right to Buy)
Direct
16K shares-
ADCT
ADC Therapeutics SA
Jun 13, 2025
Tax Payment(F)
Direct
12.6K shares at avg. $3.58$45K
PRLD
Prelude Therapeutics Inc
Jun 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
38K shares-
ADCT
ADC Therapeutics SA
Jun 3, 2025
Award(A)
Direct
40K shares-
MRUS
Merus N.V.
May 22, 2025
Award(A)
Share Option (right to buy)
Direct
13.2K shares-

		Type	Shares	Price		Ownership
Jul 1, 2026	ABCL AbCellera Biologics Inc.	Award(A) Share option (right to buy)	152,207	-	-	Direct
Jun 24, 2026	KYMR Kymera Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	6,068	-	-	Direct
Jun 9, 2026	PRLD Prelude Therapeutics Inc	Award(A) Director Stock Option (Right to Buy)	38,000	-	-	Direct
Jun 3, 2026	ADCT ADC Therapeutics SA	Tax Payment(F)	12,600	$3.08	$38,808	Direct
Jun 1, 2026	ADCT ADC Therapeutics SA	Award(A)	45,000	-	$0	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	16,604	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	13,193	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	8,844	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	14,414	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	6,120	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	8,631	-	-	Direct
Dec 12, 2025	MRUS Merus N.V.	Disposition(D) Share Option (right to buy)	17,000	-	-	Direct
Nov 5, 2025	PRLD Prelude Therapeutics Inc	Award(A) Director Stock Option (Right to Buy)	121,285	-	-	Direct
Jun 25, 2025	KYMR Kymera Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	16,000	-	-	Direct
Jun 13, 2025	ADCT ADC Therapeutics SA	Tax Payment(F)	12,600	$3.58	$45,108	Direct
Jun 12, 2025	PRLD Prelude Therapeutics Inc	Award(A) Director Stock Option (Right to Buy)	38,000	-	-	Direct
Jun 3, 2025	ADCT ADC Therapeutics SA	Award(A)	40,000	-	-	Direct
May 22, 2025	MRUS Merus N.V.	Award(A) Share Option (right to buy)	13,193	-	-	Direct

1-18 of 18 transactions

About Sandor Victor

Sandor Victor (SEC CIK 0001620368) files insider reports with the SEC as Director of AbCellera Biologics Inc. (ABCL), Director of Kymera Therapeutics, Inc. (KYMR) and Director of Prelude Therapeutics Inc (PRLD). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 12 ownership filings by Sandor Victor (1 Form 3, 11 Form 4), filed between May 27, 2025 and Jul 6, 2026. Those filings report 18 transactions, from May 22, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sandor Victor's filings is in VANCOUVER.

Recent filings by Sandor Victor

Jul 1, 2026: Grant or award of ABCL derivative securities (Form 4, code A).
Jun 24, 2026: Grant or award of KYMR derivative securities (Form 4, code A).
Jun 9, 2026: Grant or award of PRLD derivative securities (Form 4, code A).
Jun 3, 2026: Tax withholding of ADCT shares (Form 4, code F).
Jun 1, 2026: Grant or award of ADCT shares (Form 4, code A).

Other insiders filing for AbCellera Biologics Inc. (ABCL)

Hayden Michael R, Director
Montalbano John S., Director
Booth Andrew, Chief Financial Officer
Seely Lynn, Director
Quake Stephen, Director
Thermopylae Holdings Ltd., 10% Owner

How to read Form 4 transaction codes